BIOCREDIT Trademark

Trademark Overview

On Tuesday, March 22, 2022, a trademark application was filed for BIOCREDIT with the United States Patent and Trademark Office. The USPTO has given the BIOCREDIT trademark a serial number of 97323785. The federal status of this trademark filing is REGISTERED as of Tuesday, April 16, 2024. This trademark is owned by Rapigen Inc.. The BIOCREDIT trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic test kits comprised of reagents and assays for testing of bodily fluids for use in detection of COVID-19; Diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; Medical diagnostic kits and equipment, namely, medical diagnostic reagents and assays that test for the presence of viruses and infectious diseases; Medical diagnostics, namely, medical diagnostic test strips for use in detection of viruses and infectious diseases; In-vitro diagnostics, namely, drug test and medical test kits comprised of medical diagnostic reagents and assays for testing body fluids for the detection of COVID-19, malaria, influenza, dengue, hepatitis, adeno viruses, rotavirus, h.pylori, zika, syphilis, HIV, ebola, toxoplasma, chikungunya, and cardiac troponin
biocredit

General Information

Serial Number97323785
Word MarkBIOCREDIT
Filing DateTuesday, March 22, 2022
Status700 - REGISTERED
Status DateTuesday, April 16, 2024
Registration Number7361150
Registration DateTuesday, April 16, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements

Goods and ServicesMedical diagnostic test kits comprised of reagents and assays for testing of bodily fluids for use in detection of COVID-19; Diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; Medical diagnostic kits and equipment, namely, medical diagnostic reagents and assays that test for the presence of viruses and infectious diseases; Medical diagnostics, namely, medical diagnostic test strips for use in detection of viruses and infectious diseases; In-vitro diagnostics, namely, drug test and medical test kits comprised of medical diagnostic reagents and assays for testing body fluids for the detection of COVID-19, malaria, influenza, dengue, hepatitis, adeno viruses, rotavirus, h.pylori, zika, syphilis, HIV, ebola, toxoplasma, chikungunya, and cardiac troponin
Pseudo MarkBIO CREDIT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateWednesday, December 27, 2023
First Use In Commerce DateWednesday, December 27, 2023

Trademark Owner History

Party NameRapigen Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 16648
KR
Party NameRapigen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 16648
KR
Party NameRapigen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 16648
KR

Trademark Events

Event DateEvent Description
Friday, March 25, 2022NEW APPLICATION ENTERED
Friday, March 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023ASSIGNED TO EXAMINER
Thursday, January 5, 2023NON-FINAL ACTION WRITTEN
Thursday, January 5, 2023NON-FINAL ACTION E-MAILED
Thursday, January 5, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023EXAMINERS AMENDMENT -WRITTEN
Friday, April 21, 2023EXAMINERS AMENDMENT E-MAILED
Friday, April 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 21, 2023EXAMINER'S AMENDMENT ENTERED
Monday, April 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 6, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, June 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 25, 2024SOU EXTENSION 1 FILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 1 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 10, 2024USE AMENDMENT FILED
Saturday, February 10, 2024TEAS STATEMENT OF USE RECEIVED
Monday, March 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 12, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 4, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, March 11, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 16, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, June 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, June 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

biocredit medical diagnostic test reagents assays kits detection covid comprised viruses